FDA.reportPublic FDA data

maraviroc 20 MG/ML Oral Solution [Selzentry]

RxCUI
1857925
RxNorm name
maraviroc 20 MG/ML Oral Solution [Selzentry]
Display name
maraviroc 20 MG/ML Oral Solution [Selzentry]
Full name
maraviroc 20 MG/ML Oral Solution [Selzentry]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:38:56

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
SELZENTRYMARAVIROCViiV Healthcare Company46f30ac5-c96b-429e-976d-8c5ee1c0761b2022-09-26Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1857925

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
46f30ac5-c96b-429e-976d-8c5ee1c0761bSelzentry 20 MG in 1 mL Oral Solution [PSN] · maraviroc 20 MG/ML Oral Solution [Selzentry] [SBD] · Selzentry 20 MG per 1 ML Oral Solution [SY]325These highlights do not include all the information needed to use SELZENTRY safely and effectively. See full prescribing information for SELZENTRY. SELZENTRY (maraviroc) tablets, for oral use SELZENTRY (maraviroc) oral solution Initial U.S. Approval: 200720220926